HANLEY DAVID C. (Chief Technical Operations) sold 89.3% of their position (200K shares) of NUVATION BIO INC. on the open market
Open‑market sale worth $1.43M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/21/2025ACC: 0001865826-25-000004
Officer· Chief Technical Operations
Since Jun 2021
-200K
Net shares
Net seller
$1.43M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
200K acquired · 400K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
+200K
Price / share
$1.87
Trade value
$374K
% of position
833.3%
11/19/2025
24K→224K
Class A Common Stock
Direct
Shares
−200K
Price / share
$7.14
Trade value
$1.43M
% of position
89.3%
11/19/2025
224K→24K
Total
Net shares
+0.00
Net value
-$1.05M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 11/19/2025 | M · Option Exercise | +200K | $1.87 | $374K | 833.3% | 24K | 224K |
| Class A Common Stock Direct | 11/19/2025 | S · Sale | −200K | $7.14 | $1.43M | 89.3% | 224K | 24K |
| Total | +0.00 | -$1.05M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Class A Common Stock
200K shares
Shares
−200K
Strike price
1.87
Held after
300K
Exercisable
—
11/19/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Class A Common Stock200K shares | 11/19/2025 | M · Option Exercise | −200K | 1.87 | — | 300K |